Definium Therapeutics (DFTX) Goodwill & Intangibles (2021 - 2026)

Definium Therapeutics (DFTX) has reported Goodwill & Intangibles for 5 consecutive years, with $19.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Goodwill & Intangibles changed 0.0% year-over-year to $19.9 million; the TTM figure through Dec 2025 stood at $19.9 million (changed 0.0% YoY), while the FY2025 annual figure was $19.9 million, changed 0.0% from the prior year.
• Goodwill & Intangibles steadied at $19.9 million in Q4 2025 per DFTX's latest filing, from $19.9 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $26.8 million in Q4 2021 and bottomed at $1.3 million in Q3 2023.
• Historically, Goodwill & Intangibles has averaged $16.8 million across 5 years, with a median of $19.9 million in 2024.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles plunged 94.6% — and 2024, when it jumped 1412.38%.
• Definium Therapeutics' Goodwill & Intangibles stood at $26.8 million in 2021, then slipped by 11.87% to $23.6 million in 2022, then fell by 13.39% to $20.4 million in 2023, then fell by 2.58% to $19.9 million in 2024, then changed by 0.0% to $19.9 million in 2025.
• Business Quant data shows DFTX's Goodwill & Intangibles at $19.9 million in Q4 2025, $19.9 million in Q2 2025, and $19.9 million in Q1 2025.